Releases - Vitro Biopharma, Inc

Golden, Colorado—February 20, 2013—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, simultaneously accepted the resignation of Mr. Erik Van Horn from its Board of Directors and appointed Pete Shuster, the CEO of Neuromics, Inc. to its Board of Directors.  Mr. Shuster is a seasoned and experienced sales executive.  He is the current owner of Neuromics, Inc., a privately held and profitable business focused...

May Lead to Faster Recovery of Bone Fractures
Golden, Colorado—January 22, 2013—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the launch of a series of products with application to accelerated bone growth, fracture healing and development of new osteoporosis drugs.  The new products are osteoblasts derived from human adult stem cells known as mesenchymal stem cells (MSCs).  These cells...

Golden, Colorado—December 11, 2012—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the following open letter to its shareholders:

Dear Fellow Shareholders:

I am pleased to report our progress during 2012 including significant advances in our business focused on the development, manufacture and commercial distribution of essential tools to support adult stem cell research and clinical...

Distribution Partner Neuromics to Lead Sales
Golden, Colorado—October 9,  2012—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the launch of a series of products for use in the development of advanced treatment of injury and diseases of joints.  The new products are chondrocytes derived from human adult stem cells, mesenchymal stem cells (MSCs).  These cells produce collagen and are...

Golden, Colorado—September 12, 2012—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an agreement with Stemgenesis, Inc. for the exclusive distribution of its products into the following Chinese Provinces: Shanghai, Beijing, Tianjin, Jiangsu, Shandong, Zhejiang, Anhui, Fujian, Hebei, Liaoning and Heilongjiang. The agreement provides for distribution of the entire...

Golden, Colorado—August 28, 2012—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced advances in the commercialization of its infertility treatment drug, Vitropin™, a highly purified form of FSH produced through Vitro Biopharma’s patented production process. During 2011, Vitro licensed two of its patents and certain rights to other related intellectual property to Dr. James Posillico, a renowned...

Golden, Colorado—July 24, 2012—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced an expanded relationship with a key distributor of its stem cell-based products, privately-held Neuromics, Inc (www.neuromics.com).  Vitro Biopharma officials recently met Neuromics principals at their corporate headquarters in Minneapolis, MN.  Neuromics was formed in 2005 by Pete Shuster, a marketing and sales...